"Modern inquisitors-judges, we publicly pledge that for every year of prison that our brothers’ ears hear, we will put a kilo of explosives the yards of your houses, in your cars, in your offices, while we do not excluded personal face to face meetings with you, using the element of surprise approach. We think that it’s a small world and sooner or later we will meet, in the future or sooner."
Besides, as very rightly was announced by the Union of Judges and prosecutors, in a style of one thousand Cardinals, “the moment of crisis is sure to come to all of us at some point .. “. Only now it’s time for the “judges” to be judged for all those ugly acts they have committed. Since you are not ashamed to be the spearhead of the system against the insurgencies that are coming, we will make sure you feel our resentment and dislike for your dirty work. If some by judging ideas and prosecuting revolutionaries consider that they are just doing their job, then we will transfer “our work” to their homes.http://guerrillanews.wordpress.com/2011/01/07/communique-from-conspiracy-of-cells-of-fire-commando-horst-fantazzini/
Diabetes drug dapagliflozin New Drug Application submission
ReplyDeleteBristol-Myers Squibb Company and collaborator AstraZeneca has submitted to the FDA developed type 2 diabetes drug dapagliflozin new drug application for listing. The product is a new mechanism of action of hypoglycemic agents, by inhibiting sodium - dependent glucose cotransporter 2 (SGLT2) to inhibit glucose reabsorption (Nature Rev. Drug Discov. 9, 551-559; 2010). Dapagliflozin has been through more than 10 pivotal Phase III clinical trials were evaluated. From the first completed clinical trial showed that the product monotherapy, or in combination with metformin, or with glimepiride in combination are effective hypoglycemic. In addition to reducing glycosylated hemoglobin (HbA1c) levels, the drug can also reduce weight. Current security concerns about the drug can increase the urinary tract infection is. Dapagliflozin the PDUFA date (refer to FDA need to make a decision date) is October 8, 2011. The two companies also made an application in Europe. Others are in Phase III clinical trials, similar to the mechanism of action of the drug product with Boehringer's BI10773 and Johnson & Johnson's canagliflozin.
Medchemexpress Can provide the above product,its website:www.medchemexpress.com
Lenalidomide
AZD1152-HQPA
ZM-447439
Tozasertib
PHA-680632
MLN8054
JNJ-7706621
CYC-116
CCT 137690
Alisertib